Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Stem Cell Congress 2018

About Conference


ConferenceSeries Ltd invites all the participants from all over the world to attend "10th Annual Conference on Stem Cell and Regenerative Medicine" during August 13-14, 2018 at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Stem cells are cells originate in all multi-cellular organisms. They were isolated in mice in 1981 and in humans in 1998. In humans, there are several types of stem cells, each with varying levels of potency. Stem cell treatments are a type of cell therapy that introduces new cells into adult bodies for possible treatment of cancer, diabetes, neurological disorders and other medical conditions. Stem cells have been used to repair tissue damaged by disease or age. Currently, it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like the UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

Objective

Stem Cell Congress-2018 has the goal to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. Annual Conference on Stem Cell Congress 2018 will have an anticipated participation of 150+ delegates across the world to discuss the conference goal.

About Organizers

ConferenceSeries Ltd International is one of the leading Open Access publishers and organizers of international scientific conferences and events every year across USA, Europe & Asia  ConferenceSeries Ltd  has so far organized 300+ International Conferences across the World with 500+ peer-reviewed open access journals in basic science, health, and technology. ConferenceSeries Ltd International is also in association with more than 1000 International scientific and technological societies and associations and a team of 30,000 eminent scholars, reputed scientists as editorial board members.

Scientific Sessions

Stem Cell Congress-2018 will encompass recent researches and findings in stem cell technologies, stem cell therapies and transplantations, current understanding of cell plasticity in cancer and other advancements in stem cell research and cell science. Stem Cell Congress-2018 will be a great platform for research scientists and young researchers to share their current findings in this field of applied science. The major scientific sessions in Stem Cell Congress-2018 will focus on the latest and exciting innovations in prominent areas of stem cell and regenerative medicine research.

Sessions/Tracks

ConferenceSeries Ltd International Conferences invites all the participants from all over the world to attend 10th Annual Conference on Stem Cell and Regenerative Medicine during August 13-14, 2018 at London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Track : Stem Cell

An undifferentiated cell of a multicellular creature which is fit for offering ascend to inconclusively more cells of the same sort, and from which certain different sorts of cell emerge by separation. The most entrenched and generally utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat infections and states of the blood and invulnerable framework, or to restore the blood framework after medications for particular growths. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin joins for patients with serious smolders on expansive territories of the body. Just a couple of clinical focuses can do this treatment and it is normally held for patients with life-debilitating blazes. It is likewise not a flawless arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the strategy is continuous.

Track : Stem Cell Niche

A stem-cell niche is an area of a tissue that provides a specific microenvironment, in which stem cells are present in an undifferentiated and self-renewable state. Cells of the stem-cell niche interact with the stem cells to maintain them or promote their differentiation. The general niche model involves the association between resident stem cells and heterologous cell types—the niche cells.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Induced Pluripotent Stem Cells

iPSC are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic, and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications but also for basic research fields, such as development, cancer, epigenetics, and aging.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | ConferenceSeries Ltd

Track : Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells traditionally found in the bone marrow. However, mesenchymal stem cells can also be isolated from other tissues including cord blood, peripheral blood, fallopian tube, and fetal liver and lung. Multipotent stem cells, MSCs differentiate to form adipocytes, cartilage, bone, tendons, muscle, and skin. Mesenchymal stem cells are a distinct entity to the mesenchyme, embryonic connective tissue which is derived from the mesoderm and differentiates to form hematopoietic stem cells.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Cancer Stem Cells

Cancer stem cells (CSCs) are cancer cells (found in tumors or hematological cancers) that possess characteristics associated with normal stem cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Hematopoietic Stem Cells

Hematopoietic stem cells (HSCs) are multipotent, self-renewing progenitor cells that develop from mesodermal hemangioblast cells. All differentiated blood cells from the lymphoid and myeloid lineages arise from HSCs. HSCs can be found in the adult bone marrow, peripheral blood, and umbilical cord blood. More recent advances have resulted in the use of HSC transplants in the treatment of cancers and other immune system disorders.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Embryonic Stem Cells

Embryonic Stem Cells are immortal cells having an almost unlimited developmental potential. These are made from cells found in very early human embryos, called blastocysts. Many scientists are working how to create specialized cell types found in the body by exposing Embryonic Stem Cells to different conditions which they can use to treat numerous different diseases, like multiple sclerosis, blindness, and diabetes.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Adult Stem Cells

Adult stem cells are undifferentiated cells found throughout the body that divides to replenish dying cells and regenerate damaged tissues. Adult stem cell treatments have been used for many years to treat successfully leukemia and related bone/blood cancers through bone marrow transplants.
 
Scientific interest in adult stem cells is centered on their ability to divide or self-renew indefinitely, and generate all the cell types of the organ from which they originate, potentially regenerating the entire organ from a few cells.
 

Track : Stem Cell Therapy

Stem cell therapy is used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues. It additionally helps in transplanting immature microorganisms or giving medications those objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation; the recovery of the body part is not really another idea.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Stem Cell Transplantation

Stem cell transplantation, also referred to as bone marrow transplant, in which unhealthy blood-forming cells replace with healthy cells. Stem cell transplantation in combination with doses of chemotherapy or radiation therapy increases the chance of eliminating blood cancer in the marrow. Many researchers are working to improve stem cell transplantation procedures to make it an option for patients.arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the method is progressing.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Somatic Cell Therapy

Somatic cell treatment is the organization to people of autologous, allogeneic, or xenogeneic living cells which have been controlled or prepared ex vivo. Assembling of items for substantial cell treatment includes the ex vivo proliferation, development, choice. Substantial cell treatment is seen as a more moderate, more secure methodology since it influences just the focused on cells in the patient, and is not went on to future eras. Substantial quality treatment speaks to standard essential and clinical exploration, in which helpful DNA (either incorporated in the genome or as an outside episome or plasmid) is utilized to treat illness. Most concentrate on the extreme hereditary issue, including immunodeficiencies, hemophilia, thalassemia and cystic fibrosis. Such single quality issue is the great possibility for substantial cell treatment.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Regenerative Medicine

Organ and tissue loss through disease and injury motivate the development of therapies that can regenerate tissues and decrease reliance on transplantations. Regenerative medicine, an interdisciplinary field that applies engineering and life science principles to promote regeneration, can potentially restore diseased and injured tissues and whole organs.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Tissue Regeneration

Tissue Engineering is the investigation of the development of new connective tissues, or organs, from cells and a collagenous platform to create a completely useful organ for implantation over into the contributor host. Effective improvements in the multidisciplinary field of tissue building have created a novel arrangement of tissue new parts and execution approaches. Investigative advances in biomaterials, foundational microorganisms, development and separation components, and biomimetic situations have made special chances to manufacture tissues in the research facility from blends of designed extracellular networks cells and organically dynamic particles.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Regeneration and Therapeutics

Tissue regeneration therapeutics, making foundational microorganisms for supportive application in regenerative pharmaceutical. A regenerative solution is to offer the body some help with recuperating itself more sufficiently. It also develops OsteoScaf, a biodegradable, fully resorbable, and osteoconductive scaffold for use in healing tissue defects. In regenerative pharmaceutical, cell, tissue and organ substitutes are made to restore normal limit that has been lost.
 

Track : Stem Cell Apoptosis and Signal Transduction

Self-replication and proliferation of stem cell populations are controlled, by induction of apoptosis. The number of stem cells is, therefore, a balance between those lost to differentiation/apoptosis and those gained through proliferation. Apoptosis of stem cells is believed to be a dynamic process which changes in response to environmental conditions. For example, the release of stem cell factor inhibits apoptosis following spinal cord injury, presumably in an attempt to promote tissue repair. Dysregulation of apoptosis in stem cells is believed to underlie some cancer pathologies, where apoptotic resistance results in uncontrolled growth (i.e. glioblastoma). Controlling apoptosis is also an important focus for studies of stem cell transplantation, where inhibition may increase the survival of grafted cells during replacement therapy. Harnessing the full therapeutic potential of stem cells will require full elucidation of the signal transduction cascades for proliferation, differentiation, and apoptosis.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Immunological Challenges for Stem Cells

Stem cells have a huge potential for treating disease but one challenging area is that involving a patient's immune system. Also, the increasing numbers of stem cell therapies are entering clinical trials and the issue of the immunological consequences are also unusual and it's important to understand what exactly happens during immune rejection before looking at the different immunological consequences from the use of embryonic stem cells.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track: Computational Stem Cell Biology & Systems Biology

Computational Biology sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformatics develop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track :  Novel Stem Cell Technologies

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective stem cell treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage differentiation. Most development is in developing cell culture media, cell separation products, instruments and other reagents for use in stem cell immunology, cancer, regenerative medicine and cellular therapy research.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Stem Cell BioBanking & Tissue Preservation

Stem cell banking through long-term storage of different stem cell platforms represents a fundamental source to preserve original features of stem cells for patient-specific clinical applications. Stem cell research and clinical translation constitute fundamental and indivisible modules catalyzed through biobanking activity, generating a return of investment.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track : Biomaterials & Stem Cells

Biomaterials and stem cell has the potential for the treatment of diseases to the repair and regeneration of the organs. Modern stem cells in regenerative medicine is mainly using three-dimensional structured biomaterials in combination with stem cells as a cell source. Biomaterial scaffolds are developed that not only serve as cell carriers providing mechanical support, but actively influence cellular responses including cell attachment and proliferation. Researchers are working in the field of identification of biomaterials which is most suitable for stem cells in regenerative medicine.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Track :  3D Bioprinting & Biofabrication

3D Bioprinting aids stem cells in tissue engineering by providing an in-depth information of the image and structure analysis of the image. Biofabrication is referred to the production of artificial tissues or organs to address health challenges in medicine. It often uses the principle of 3D Bioprinting to form cells, gels, and fibers into an organ.

Related Stem Cell Conferences | Stem Cell Congress | Regenerative Medicine Conferences | Stem Cell Meetings

Market Analysis

Market Analysis Report:

Stem cell Regenerative Medicine is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which “replaces or regenerates human cells, tissues or organs, to restore or establish normal function” and deploys small molecule drugs, biologics, medical devices and cell-based therapies.

 

Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole.The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

 

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Cell Therapy Market, By Region, 2009 2018

$Million

 

Major Stem Cell Organization Worldwide:

·  Norwegian Center for Stem Cell Research

·  France I-stem

·  Stem Cell & Regenerative Medicine Ctr, Beijing

·  Stem Cell Research Centre, Korea

·  NSW Stem Cell Network

·  Monash University of  Stem Cell Labs

·  Australian Stem Cell Centre

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

 Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.


Figure 2: Global Market

Companies working for Stem Cells:

Company

Location

Business Type

Cynata Therapeutics

Armadale, Australia

Stem Cell Manufacturing Technology

Mesoblast

Melbourne, Australia

Regenerative Medicine

Activartis

Vienna, Austria

Dendritic Cell-Based Cancer Immunotherapy

Aposcience

Vienna, Austria

Treatments composed of mixture of cytokines, growth factors and other active components

Cardio3 Biosciences

Mont-Saint-Guibert, Belgium

Stem Cell Differentiation

Orthocyte (BioTime)

Alameda, CA

Cellular Therapies

Capricor

Beverly Hills, CA

Stem Cell Heart Treatments

Life Stem Genetics

Beverly Hills, CA

Autologous stem cell therapy

International Stem Cell

Carlsbad, CA

Proprietary Stem Cell Induction

Targazyme

Carlsbad, CA

Cell Therapy

DaVinci Biosciences

Costa Mesa, CA

Cellular Therapies

Invitrx Therapeutics

Irvine, CA

Autologous Stem Cell Therapy, Therapeutic & Cosmetic

 

Past Conference Report

Stem Cell Congress 2017

Stem Cell Congress 2017 Report

9th Annual Conference on Stem Cell and Regenerative Medicine was organized during September 25-26, 2017 at Berlin, Germany. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Frontiers in Stem Cells & Regeneration” which included the following scientific tracks:  

Stem Cell Therapy

Stem cell

Stem cell treatment

Somatic Cell Therapy

Tissue Regeneration

Regeneration and Therapeutics

Tumour cell science

Cell & Gene therapy

Stem Cell Biomarkers

Stem Cell Bio banking & Tissue preservation

Stem Cell Technologies

Stem Cell Nano-Technology

Stem Cell Apoptosis and Signal Transduction

Tissue science & Engineering

Novel Approaches in GTR

Potential Applications of Stem cell Therapy

Regenerative Medicine and Market

Stem cell-Bioinformatics

Biomaterial Engineering

 

The Organizing Committee would like to thank the moderator Dr Andriana Margariti (Queen's University Belfast, UK) and Dr Francesco Neri (Leibniz Institute on Aging – Fritz Lipmann Institute, Germany) for their contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Richard George Pestell CCR5 governs stem cell characteristics, therapy resistance and metastasis of breast cancer (Pennsylvania Cancer and Regenerative Medicine Research Center, USA)

Roohi S Ahmad- Vascular tissue regeneration from implantation of 3D bio-printed stem cell grafts in rhesus monkeys (Sichuan 3D Bio-printing Institue, China)

Y James Kang -Rejuvenation therapy for ischemic heart disease (Sichuan University, China)

 

Various sessions were chaired by: Richard George Pestell - Pennsylvania Cancer and Regenerative Medicine Research Center, USA; Tamara Lah Turnšek- Mednarodna podiplomska šola Jo┼żefa Stefana, Slovenia; and co-chaired by Joseph Choukroun- Pain Clinic, France; Viacheslav M Mikhailov- Institute of Cytology - Russian Academy of Sciences, Russia

ConferenceSeries LLC has taken the privilege of felicitating Stem Cell Congress -2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Stem Cell Congress-2017. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Stem Cell Research & Therapy: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, ConferenceSeries LLC would like to proudly announce the commencement of the "10th Annual Conference on Stem Cell and Regenerative Medicine" to be organized during August 13-14, 2018 at London, UK.

 Mark your calendars for the upcoming Conference; we are hoping to see you soon!


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date August 13-14, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Stem Cell Research & Therapy Journal of Genetic Syndromes & Gene Therapy Journal of Cell Science & Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos